Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @JTrentMDPhD
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @JTrentMDPhD
-
Jon Trent, MD, PhD proslijedio/la je Tweet
Looking forward to it, great science and venue! I am coordinating the patient/advocacy track. Happy to send information to all interested in attending!
#advocacy#Survivors#MetastaticDisease#research#MiamiPrecisionMedicineConferencehttps://twitter.com/carmencalfa/status/1222677138932948993 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je Tweet
Bonding for a cause! Please consider joining my
#DCC team to support innovative#research@SylvesterCancer#TackleCancer https://www.youtube.com/watch?v=ahVXSC0bEbY … https://twitter.com/CarmenCalfa/status/1194705385027821568 …pic.twitter.com/niCMvMThcJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je Tweet
Grateful to the women physicians specializing in
#oncology who take such great care of our cancer patients.#NationalWomenPhysiciansDaypic.twitter.com/DKVo18yEsi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je Tweet
Only 6 weeks to go! Join us
@TheBSG_UK#sarcoma#conference in#Glasgow. What Matters to you- matters to us.Working together to improve#care for people with sarcoma & their families.@Amocras@AndrewCrummy@Sarcoma_UK@jasonleitch@charlottebenson@12crchttps://twitter.com/Ioanna_Nixon/status/1202966238953119744 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je Tweet
Join us
@BSG2020 Conference, 26&27 February 2020. Civic reception#Glasgow City Chambers on the 25th. Thanks to all my colleagues from Scottish Sarcoma Network &@TheBSG_UK for the hard work to prepare this programme. “What matters to you- matters to us”.pic.twitter.com/F1JyM9cY7B
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Jon Trent, MD, PhD proslijedio/la je Tweet
#Trentselfie ... something to add to the advocacy bucket list!?#DesmoidTumourAwareness#DesmoidFibromatosis#AggressiveFibromatosis#PatientAdvocacy#RareDiseasehttps://twitter.com/sarcomapatients/status/1224377462974570498 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Jon Trent, MD, PhD proslijedio/la je Tweet
It was an honour to have you join, thanks for discussing with us!
#StrongerTogether#sarcoma#GIST#desmoidhttps://twitter.com/winette_vdgraaf/status/1224028570315608066 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je Tweet
There are resources designed to help you in your
#desmoid journey, such as the@SarcomaAlliance program “Hand in Hand” offering financial assistance for a single 2nd opinion consultation. Find this program & more within DTRF Patient Resources.https://dtrf.org/patient-resources/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je Tweet
maybe some tools like nomograms help ... but the questions are increasingly interesting and not only yes or no, also with what drugs, and how to assess the answer ...
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je Tweet
Don't forget to purchase your all-inclusive friends and family tickets for the Finish Line Festival presented by Moss Construction. Get your tickets >> http://bit.ly/2v9gM96 pic.twitter.com/HBvVgD6kja
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je Tweet
Awesome support
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Learned a ton today! Looking forward to days 2 and 3!https://twitter.com/myesmo/status/1224403461091053568 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je Tweet
#ESMOSarcoma20: Great first day merging both the clinical and the translational perspectives in#rarecancers such as#STS &#GIST. Over 530 participants here with us (new record)
http://ow.ly/rtE030qeEdi #scmsm@casali_pg@apdeitos@jeanyvesblay@JTrentMDPhDpic.twitter.com/V0shYOlt9V
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je Tweet
In the 1910s, the
@AmerMedicalAssn -sponsored Flexner reforms led to the closing of all but one women medical colleges, drastically reducing the proportion of female MDs to an all-time low of 2.8%. The rate would not recover until the 1970s#NationalWomenPhysiciansDay#NWPDPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jon Trent, MD, PhD proslijedio/la je Tweet
So important
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Distinguishing small round blue cell sarcomas by Chris Fletcher
@DanaFarber @myESMO#sarcoma @JMGardnerMD @LizMontgomeryMD @DrBuiPathology @PathologySayah @AMPathpic.twitter.com/nahvGj0iu2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ran into
@Winette_vdGraaf@myESMO#sarcoma. Great to hear about her work in clinical trials and QOL.pic.twitter.com/HmKuGFnajs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
